Requirements quality is central to successful software and systems engineering. Empirical research on quality defects in natural language requirements relies heavily on datasets, ideally as realistic ...
Shares of certain biotech firms were rising ahead of market open on Monday on news of the departure of the FDA’s vaccine chief, Dr. Vinay Prasad. Prasad, the head of the FDA’s division of vaccines and ...
uniQure N.V.’s (NASDAQ: QURE) shares surged after news that Dr. Vinay Prasad will step down from leading the U.S. Food and Drug Administration’s biologics division. On Friday, FDA Commissioner Marty ...
uniQure (QURE) stock surged 36% after FDA CBER director Vinay Prasad announced his April departure, sparking analyst upgrades and a biotech rally. uniQure (QURE) stock surged 36% Monday after FDA’s ...
Shares of uniQure (QURE) climbed 36% on Monday following news that Vinay Prasad will step down from his role at the FDA’s Center for Biologics Evaluation and Research Prasad had been responsible for ...
uniQure (NASDAQ: QURE) shares finished the regular trading week down only 9% despite the FDA’s hard-line stance and public criticism against the company’s Huntington’s disease (HD) gene therapy ...
Shares of uniQure N.V. QURE plunged 31.8% in a week, primarily after the company announced a disappointing regulatory update for its investigational gene therapy, AMT-130, for the treatment of ...
NEW YORK, March 5, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) ...
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., by brothers David and Tom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results